appears in the following:

FDA Releases Long-Awaited COVID-19 Vaccine Guidance

Tuesday, October 06, 2020

The requirements laid out by the Food and Drug Administration in advice for drugmakers underscore why it's unlikely a vaccine could clear the agency before Election Day.

Comment

How Operation Warp Speed's Big Vaccine Contracts Could Stay Secret

Tuesday, September 29, 2020

More than $6 billion in federal funding has been routed through a firm that manages defense contracts, making the agreements subject to less federal scrutiny and transparency.

Comment

What To Know About Those $200 Drug Cards President Trump Promised

Friday, September 25, 2020

Health policy researchers say Trump may not be able to pay for the cards, which fall short of lasting policy changes to curb high drug prices.

Comment

CDC Releases Plan For Coronavirus Vaccine Distribution

Wednesday, September 16, 2020

The Centers for Disease Control and Prevention released plans for the distribution of coronavirus vaccines. The logistical challenges could be as daunting as the scientific ones.

Comment

9 Companies Pledge Not To Submit Coronavirus Vaccine To FDA Until It's Proved Safe

Tuesday, September 08, 2020

To reassure the public, nine companies issued a joint statement Tuesday saying they won't seek government approval for their coronavirus vaccines until full safety and effectiveness data are in hand.

Comment

How Feds Decide On Remdesivir Shipments To States Remains Mysterious

Wednesday, August 19, 2020

The federal government is in charge of distributing one of the few treatment options for COVID-19: the antiviral drug remdesivir. But how are decisions made about which states need it most?

Comment

Prices For COVID-19 Vaccines Are Starting To Come Into Focus

Thursday, August 06, 2020

Moderna, one of the leading horses in the coronavirus vaccine race, has already made deals at between $32 and $37 a dose for some foreign countries. The U.S. price is expected to be lower.

Comment

U.S. Reaches $2.1 Billion Deal With Sanofi, GlaxoSmithKline For COVID-19 Vaccine Push

Friday, July 31, 2020

This is the sixth vaccine candidate to join Operation Warp Speed's portfolio, and the largest vaccine deal to date.

Comment

Trump Signs Executive Orders On Drug Prices

Friday, July 24, 2020

The president says the actions will lower drug prices, but policy experts say they will likely offer patients only minimal relief and may take months to implement, if they're implemented at all.

Comment

U.S. To Get 100 Million Doses of Pfizer Coronavirus Vaccine In $1.95 Billion Deal

Wednesday, July 22, 2020

If the company's vaccine candidate pans out, Americans can receive it for free under the deal. The arrangement is part of the U.S. government's push to have a vaccine widely available by January.

Comment

Early Oxford-AstraZeneca Coronavirus Vaccine Data 'Encouraging,' Scientists Say

Monday, July 20, 2020

Testing in more than 1,000 people found the vaccine spurred an immune response and had no severe side effects. Larger trials are underway.

Comment

'Meaningless' FDA Certificates Are Used To Tout Dubious Face Masks

Thursday, July 16, 2020

Companies that made hats, socks and teddy bears have started producing surgical masks to protect people from COVID-19. Some sellers exaggerate their standing with the Food and Drug Administration.

Comment

Remdesivir Priced At More Than $3,100 For A Course Of Treatment

Monday, June 29, 2020

An experimental COVID-19 medicine that has been shown to shorten the time people with severe illness have to stay in the hospital finally has a price tag that's lower than some analysts expected.

Comment

Questions About How Crash Program Is Picking Coronavirus Vaccines To Back

Friday, June 12, 2020

As Operation Warp Speed pushes to develop a COVID-19 vaccine in record time, the number of candidates is being narrowed. The factors guiding the decisions about which projects to fund is unclear.

Comment

Remdesivir 101: What Is This Drug, Are There Alternatives And How Much Might It Cost?

Tuesday, May 19, 2020

Various experimental drugs are being studied as potential COVID-19 treatments, but remdesivir is the furthest along right now. The federal government has already shipped remdesivir to all 50 states.

Comment

Remdesivir Distribution Causes Confusion, Leaves Some Hospitals Empty-Handed

Thursday, May 14, 2020

Gilead Sciences is donating its initial supply of the experimental treatment for COVID-19. The federal government is deciding where the scarce medicine goes, and there are questions about the choices.

Comment

Putting A Price On COVID-19 Treatment Remdesivir

Friday, May 08, 2020

Gilead Sciences has committed to donating the initial supply of the experimental antiviral drug. But executives said the company will need to make expanded production of the treatment sustainable.

Comment

Gilead Lobbying Rose As Interest In COVID-19 Treatment Climbed

Saturday, May 02, 2020

On Friday, the Food and Drug Administration authorized emergency use of remdesivir for patients with severe cases of COVID-19. Drugmaker Gilead Sciences' lobbying hit a new high in the first quarter.

Comment

What Would It Take To Bring More Pharmaceutical Manufacturing Back To The U.S.?

Friday, April 24, 2020

Experts say it could be dangerous to rely on overseas production of medicine in a crisis, but the U.S. largely does. Rebuilding domestic capacity would take years and substantial investments.

Comment

Coronavirus Pandemic Brings Hundreds Of U.S. Clinical Trials To A Halt

Saturday, April 11, 2020

COVID-19 has led to the suspension of many clinical studies of experimental treatments. About a quarter of the stopped trials involved new cancer treatments, an NPR analysis finds.

Comment